Casa Produtos Suprimentos para Testes Médicos

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Name: Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection
Brand: Sichuan Hundred Medcal Technology Co., Ltd.
SKU: /
Availability: InStock

Todos os Produtos

Dispositivo Médico Domiciliar
(42)

Suprimentos de proteção médica
(13)

Dispositivo dental médico
(23)

Consumíveis cirúrgicos
(35)

Analista Médico
(12)

Suprimentos para Testes Médicos
(19)

Equipamento de diagnóstico médico
(41)

Equipamento de salvamento de emergência
(13)

Equipamento de terapia respiratória
(5)

equipamento de monitoramento médico
(10)

Produtos médicos de saúde
(25)

Fontes sem fôlego do cuidado
(6)

Equipamento de Esterilização Médica
(1)

Equipamento Médico de Reabilitação
(14)

Equipamento Hiperbárico
(2)

Certificado

China Sichuan Hundred Medcal Technology Co., Ltd. Certificações

Estou Chat Online Agora

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Imagem Grande : Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

Detalhes do produto:

Lugar de origem:	China
Marca:	HDRMEDICO
Certificação:	CE
Número do modelo:	/

Condições de Pagamento e Envio:

Quantidade de ordem mínima:	500 unidades
Preço:	Negociável
Detalhes da embalagem:	Caixa
Tempo de entrega:	10-15 dias
Termos de pagamento:	L/C, T/T, Westen Union, Money Gram, PayPal/VTB
Habilidade da fonte:	100.000 unidades/mês

Contato Converse agora

Chikungunya Virus Rapid Test Cassette Colloidal Gold for IgM/IgG Antibody Detection

descrição

Nome do produto:	Cassete de teste rápido do vírus Chikungunya	Material:	Plástico
Categoria de produto:	Diagnóstico in vitro	Método:	Método do ouro coloidal
Prazo de validade:	Dois anos	Função:	Detecção
Destacar:	Chikungunya virus rapid test cassette , Colloidal gold antibody detection test , IgM IgG rapid test cassette

Chikungunya Virus Rapid Test Cassette

This in vitro diagnostic device utilizes immunochromatographic (colloidal gold) technology for the rapid, qualitative detection of anti-Chikungunya virus IgM and IgG antibodies in human serum, plasma, or whole blood samples.

Technology & Methodology

The test operates on a lateral flow immunoassay principle. Recombinant Chikungunya virus antigens are immobilized on the nitrocellulose membrane at distinct test lines (T-IgM and T-IgG). When a sample is applied, anti-CHIKV antibodies bind to the antigen-colloidal gold conjugate, forming visible colored lines at the respective test lines.

Intended Use & Clinical Applications

This rapid test serves as an important aid in the presumptive diagnosis of recent or past Chikungunya virus infection, particularly useful in:

Outbreak Settings: Rapid screening of febrile patients in areas with active CHIKV transmission
Differential Diagnosis: Distinguishing Chikungunya fever from other clinically similar arboviral diseases such as dengue or Zika virus infection
Case Management: Supporting clinical decision-making for patients with acute onset of high fever and severe joint pain

Key Features & Advantages

Rapid Results: Visual results typically within 10-20 minutes for quick clinical triage
Simultaneous Detection: Detects both IgM (recent infection) and IgG (later stage or past infection) antibodies from a single sample
Ease of Use: Simple procedure requiring minimal training and no specialized laboratory equipment
High Clinical Utility: Positive IgM result with compatible symptoms strongly suggests acute Chikungunya infection

Result Interpretation

Result	Interpretation
IgM Positive	Suggests recent or current Chikungunya virus infection
IgG Positive	Indicates later-stage or past infection/exposure
Both IgM & IgG Positive	Common during the convalescent phase
Negative	No detectable levels of anti-CHIKV antibodies (does not completely rule out early infection)
Invalid	Control line (C) fails to appear - test must be repeated

Important Notes

This is a screening test. All reactive results, especially in low-prevalence areas, should be confirmed by more specific serological methods (ELISA, PRNT) or molecular tests (RT-PCR) in a reference laboratory. Test performance may vary depending on sample collection timing relative to symptom onset. Clinical history and epidemiological context are essential for accurate diagnosis.

etiqueta:

Pessoa de Contato: Mr. Terry

Telefone: 15008220675

Outros Produtos